BAY AREA PHARMACOKINETIC AND PHARMACODYNAMICS (BAPKPD) NETWORK

invites you our annual

2017 Poster Social Event


Tuesday, April 18th, 2017

1:00-5:00 PM PDT

Genentech

Building 24, Room 1N 

South San Francisco, CA 94080
(Parking at 455 E Grand Ave, About 5 minutes walk to building 24)


Please visit the sponsor of our seminar:

Simulations Plus Quintara

Summary:

In this annual Bay Area Pharmacokinetic and Pharmacodynamics Network (BAPKPD) event, posters that have already been presented at other meetings get a 'second chance' to be displayed for the benefit of the scientific community of the Bay Area. The posters and podia will showcase the use of PK/PD modeling and simulation in drug research, safety assessment, clinical pharmacology, clinical trial design, regulatory dossiers, etc. All attendee’s will receive a ticket for an iPad mini raffle. Attendee’s presenting posters will receive an additional ticket.

 

Abstract Submission:

To submit your abstract, please complete the abstract submission form. Also indicate on the form, if you are interested in presenting your poster in the podium session. Email the completed abstract submission form no later than April 11, 2017 to abstracts@bapkpd.org.

 

Agenda:

1:30-2:00 pm: Registration, poster setup, browsing posters and networking (refreshments and hors d 'oeuvres)

 

2:00-3:20 pm: Plenary Podium Presentation

2:00-2:40 pm: Integrating Drug-Target Kinetics into Predictions of Drug Activity
Pete Tonge, Professor of Chemistry and Radiology at Stony Brook University

Peter Tonge is a Professor of Chemistry and Radiology at Stony Brook University. He is the co-Director of the NIH-funded T32 Chemical Biology Training Program, and Director of the Bio-molecular Imaging Faculty Cluster. He is also an Associate Editor for ACS Infectious Diseases. A primary interest of his program is to develop enzyme inhibitors that have extended target engagement, which should enable reduced dosing frequency and exposure, resulting in decreased side effects, increased compliance and reduced drug resistance. This is aided by the development of PK/PD models that integrate drug-target kinetics into the prediction of drug activity in humans, and the use of positron emission tomography to non-invasively image drug biodistribution.

2:40-3:20 pm: Model Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab

Bing Wang, PhD, Director, Clinical Pharmacology-DMPK, MedImmune LLC

Bing Wang is a MedImmune Fellow (Director) in the Clinical Pharmacology and Pharmacometrics group. He has 20 years of experience in clinical PKPD and 17 years of industry experience in the nonclinical and clinical development of small molecules and biotherapeutics across multiple therapeutic areas. Dr. Wang has led several project teams in hematology, oncology, pulmonary disease and RIA, built a clinical PKPD function group, and contributed to multiple regulatory filings. Dr. Wang has been an invited speaker at many international conferences and chaired several symposiums at ASCPT and AAPS. Before joining MedImmune, Dr. Wang worked as a pharmacokineticist at Amgen and a clinical pharmacologist at Abgenix.

3:20-3:30 pm: Break

3:30-4:10 pm: BAPKPD Member Podium Presentation

4:10-5:00 pm: Poster Session and Social

 

Registration Registration is now closed. Space is limited and registration will be closed when capacity is reached.

Standard registration [April 3, 2017 and closes on April 14, 2017]: $20 per person
($10
for pre-approved full-time students, postdocs, and the unemployed, see below).

No on-site registration available.

For questions about the event and for pre-approval of special registration fees, please contact Richard Zang at zang.xu@gene.com

 

Home - Job Listings - Upcoming Events - Other Local Events - Previous Events

Become a Member - Advisory Committee - Steering Committee - BAPKPD Contact